Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
January 2025: ELFA CapEx Finance Index Shows Demand Pulled Forward from Jan. to Dec.
-
Searching for Spring: New Drinks & App Rewards at The Human Bean
-
Allarity Therapeutics Announces Dismissal of Securities Class Action Lawsuit
-
Freename partners with Chiliz: .CHZ Domains Are Here
-
MT Højgaard Holding A/S: Reporting of trading in MT Højgaard Holding A/S shares by senior management
-
Transactions by persons discharging managerial responsibilities and/or persons closely associated
-
Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market
-
GOGL – Q4 2024 Presentation
-
Toobit Boosts Security Measures: Introducing AI-Driven Monitoring, Multi-Factor Authentication, and Strengthened Cold Wallet Management
-
Hillman to Present at the Raymond James 46th Annual Institutional Investors Conference
-
Applied Materials to Participate in the Cantor Fitzgerald Global Technology Conference
-
VR Resources Confirms PGE and Nickel-Copper Fertility at Empire Project in Northwest Ontario
-
Amerigo Announces 2024 Results & Quarterly Dividend
-
Orange County Transportation Authority awards contract for 50 zero-emission buses from NFI subsidiary New Flyer
-
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care
-
Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases
-
Papa Johns Raises $73,411 for Canadian Nonprofit
-
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
-
American Tungsten Announces Closing of Upsized and Oversubscribed Non-Brokered LIFE Offering of Shares
-
DT Midstream Reports Record 2024 Results; Raises Dividend and 2025 Adjusted EBITDA Guidance
-
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
-
Amerigo Announces 2024 Results & Quarterly Dividend
-
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
-
Rekor’s Vehicle Insite Application Deployed to Study Electric Vehicle Movement Across 90 Sites in the Phoenix Metropolitan Area
-
Kelly Establishes Integrated Permanent Hiring Solutions Business Line Across KellyOCG and Sevenstep
-
Colliers ranked among top three commercial real estate brands for eighth consecutive year
-
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
-
Mavenir and O2 Telefónica Germany Strengthen Partnership with Multi-Year IMS Contract Extension for Cloud-Native IMS Services
-
AVANTE ANNOUNCES 21% REVENUE GROWTH AND 74% ADJUSTED EBITDA GROWTH FOR Q3 FISCAL 2025
-
Bio Usawa Appoints Dr. Patrick Lukulay as Chief Operating Officer
-
Verisk Reports Fourth-Quarter 2024 and Full-Year 2024 Financial Results
-
CryoMass Announces Sale of CryoSift Separator™ and License of Its Cryogenic Refinement Technology in Oklahoma Market
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 25 02 2025] - (CGWL)
-
Goliath Resources Presenting At Metals Investors Forum (MIF) February 28ᵗʰ - March 1ˢᵗ And PDAC 2025, March 2ⁿᵈ - 5ᵗʰ, Booth # 3234
-
Form 8.3 - [ALLIANCE PHARMA PLC - 25 02 2025] - (CGWL)
-
Kraig Biocraft Laboratories Achieves Breakthrough In Recombinant Spider Silk Design Complexity
-
Dycom Announces Authorization of a New $150 Million Stock Repurchase Program
-
Avista Corp. Reports 2024 Results and Initiates 2025 Earnings Guidance
-
Astec Reports Record Fourth Quarter, Full Year 2024 Results
-
Sprott Announces Year Ended 2024 Results
-
Tenapanor Approved in China for Hyperphosphatemia
-
Fury Gold Mines Limited to Acquire Quebec Precious Metals Corporation
-
Metsera to Present at TD Cowen’s 45th Annual Health Care Conference
-
Chicago Atlantic Real Estate Finance Schedules Fourth Quarter 2024 Earnings Release and Conference Call Date
-
Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
-
Antitrust, Intellectual Property, Digital Platforms and International Business Expert Professor Daniel Spulber Affiliates with Compass Lexecon
-
Metallurgical Test Work confirms > 95% Lithium Extraction from Acid Leach on High-Grade Mineralization Samples from Bonnie Claire
-
Rocky Shore Stakes Gold-Bearing Appleton Fault Corridor at Gold Anchor Project
-
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compe
-
EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
